- Home
- ZNTL vs NNOX Comparison
ZNTL vs NNOX Comparison
Compare ZNTL & NNOX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ZNTL | NNOX |
|---|---|---|
| Founded | 2014 | 2011 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical Electronics |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 162.5M | 159.5M |
| IPO Year | 2020 | 2020 |
Fundamental Metrics
Financial Performance| Metric | ZNTL | NNOX |
|---|---|---|
| Price | $2.50 | $2.46 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 5 | 2 |
| Target Price | $6.60 | ★ $7.00 |
| AVG Volume (30 Days) | 1.1M | ★ 1.3M |
| Earning Date | 03-25-2026 | 11-20-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $26,865,000.00 | $12,302,000.00 |
| Revenue This Year | N/A | $20.19 |
| Revenue Next Year | N/A | $137.69 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 15.19 |
| 52 Week Low | $1.01 | $2.27 |
| 52 Week High | $3.95 | $7.60 |
Technical Indicators
Market Signals| Indicator | ZNTL | NNOX |
|---|---|---|
| Relative Strength Index (RSI) | 50.37 | 37.89 |
| Support Level | $2.21 | $2.27 |
| Resistance Level | $2.85 | $2.47 |
| Average True Range (ATR) | 0.29 | 0.22 |
| MACD | -0.09 | -0.05 |
| Stochastic Oscillator | 25.93 | 18.40 |
Price Performance
Historical ComparisonAbout ZNTL Zentalis Pharmaceuticals Inc.
Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing azenosertib (ZN-c3), a potentially first-in-class and best-in-class WEE1 inhibitor for patients with Cyclin E1-positive platinum-resistant ovarian cancer (Cyclin E1+ PROC). The Company manages its operations as a single segment for the purposes of assessing performance and making operating decisions.
About NNOX NANO-X IMAGING LTD
Nano X Imaging Ltd is engaged in the business of manufacturing medical imaging systems. It offers a Nanox System which is a combination of hardware and software. It develops a prototype of the Nanox.ARC, a medical imaging system incorporating its novel digital X-ray source; and Nanox.CLOUD, a companion cloud-based software that will allow for the delivery of medical screening as a service. It has three business segments: Nanox.ARC division, the radiology services division and the AI solutions division. Key revenue is generated from Radiology Services.